Takeji Umemura

39PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersAutoimmunityCardiology (incl. cardiovascular diseases)Gastroenterology and hepatologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jan 07, 2026
Predictive Value of Serum Autotaxin for Hepatocellular Carcinoma Recurrence After Curative Radiofrequency Ablation.

Takanobu Iwadare, Hiroyuki Kobayashi, Takefumi Kimura

|Oct 15, 2024
Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.

Takanobu Iwadare, Takefumi Kimura, Ayumi Sugiura

|May 25, 2024
Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis.

Ichitaro Horiuchi, Kaori Horiuchi, Akira Horiuchi

|Apr 16, 2024
Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.

Takanobu Iwadare, Takefumi Kimura, Taiki Okumura

|Feb 24, 2024
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease.

Nobuharu Tamaki, Shun-Ichi Wakabayashi, Takefumi Kimura

|Feb 01, 2024
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.

Ayaka Tanifuji, Satoko Ohfuji, Kosuke Matsumoto

Pageof 7

Frequent Collaborators

21 joint publications

Satoru Joshita

7 joint publications

Yuki Yamashita

6 joint publications

Ayumi Sugiura

5 joint publications

Naoki Tanaka